European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Targeting the metabolism-immune system connections in Cancer

Description du projet

Interaction cancer-cellules immunitaires: le rôle du métabolisme

Les cellules cancéreuses présentent une croissance et une prolifération rapides. Par rapport aux cellules normales, elles ont développé des caractéristiques métaboliques uniques leur permettant de répondre à leurs besoins énergétiques accrus. En outre, le métabolisme associé au cancer peut influencer le microenvironnement tumoral, y compris la fonction des cellules immunitaires et les stratégies d’évasion immunitaire employées par les cellules cancéreuses. Financé par le programme Actions Marie Skłodowska-Curie, le projet META-CAN vise à étudier comment les niveaux de nutriments et d’oxygène régulent les interactions entre les tumeurs et le système immunitaire. Ces travaux permettront de mieux comprendre la réponse immunitaire anticancéreuse et ouvriront la voie à de nouvelles possibilités thérapeutiques avec des médicaments ciblant le métabolisme des cellules cancéreuses et immunitaires.

Objectif

"Cancer cells show common features of profound metabolic changes and escape from the immune system, independently of their tissue of origin. These metabolic adaptations are not limited to glucose metabolism (the ""Warburg effect"") but are more general and affect several metabolic pathways in cancer cells as well as in the stroma, including immune cells. This network will explore how nutrients and hypoxia regulate the tumor-immune system interplay, and how this communication is controlled by oncogenes, metabolic regulators and current or potential drugs targeting metabolism.
Understanding how metabolism can affect tumor cells and the anti-cancer immune response represents a potential therapeutic intervention point that can be exploited to develop novel therapies and new diagnostic and prognostic markers. The development of therapies targeting cancer metabolism is hampered by: 1) the complexity of the regulation that metabolism exerts on many different tumor layers, which requires multidisciplinary collaborations, and 2) the shortage of scientists that can navigate with ease between academic, industrial and clinical sectors and have the scientific and complementary skills to convert research findings into commercial and clinical applications.
This network provides a pan-European interdisciplinary and intersectoral training program of excellence bringing young researchers together with World leading academics, clinicians, pharma industry members, corporate research and dissemination and outreach specialists. As part of the research training, the consortium will conduct a coherent and integrated set of hypothesis-driven research projects that are aimed at discovering, describing and exploiting how metabolism at the cell and the whole body levels is integrated with modulation of cell death susceptibility and the immune response in the context of cancer.
"

Coordinateur

FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE
Contribution nette de l'UE
€ 743 618,88
Adresse
AVENIDA GRAN VIA HOSPITALET 199-203
08908 L'Hospitalet De Llobregat
Espagne

Voir sur la carte

Région
Este Cataluña Barcelona
Type d’activité
Research Organisations
Liens
Coût total
€ 743 618,88

Participants (12)

Partenaires (7)